Josh Borja works at ASHM, supporting the delivery of the HIV s100 Prescriber Course and its associated ongoing education. His work focuses on high-quality training, accreditation, and continuous professional development, helping prescribers build confidence, maintain currency, and strengthen HIV care across Australia. This work extends across the broader blood-borne virus sector, including viral hepatitis. He facilitates "Ask Us Anything" sessions that put lived experience at the centre of clinician training, and embeds stigma-reduction frameworks such as PozQoL into clinical education.

A/Prof Thomas Tu leads the Hepatitis B research group at the Westmead Institute for Medical Research and is a world leader Hepatitis B virology. Drawing on lived experience of hepatitis B, he is committed to translational research that improves outcomes for affected communities.

Esha Leyden is a Peer Harm Reduction Worker at QuIHN (Queensland Injectors Health Network.) And also, a AIVL (Australian Injecting and Illicit Drug Users League) Vise President Esha has worked in the drug sector for the past 13 years and has been a member of the drug-using community for the past 38 years. Esha has lived experience in a hepatitis C and treatment, Justice and custodial setting, and injecting drugs use, which allows her to understand the challenges and stigma/ Discrimination faced by the community and their ongoing needs. Esha has been a part of many forums, symposiums and committees and presenting at various state and national conferences on my lived experience and advocated for people who inject drugs. Esha was one of the main people and the Queensland Rep for the ‘IT’S YOUR RIGHT’ National peer health Campaign for Hepatitis C.

Pete has Lived Experience of HIV (40+yrs) and HCV. He has worked at Hepatitis WA for 7 years in various roles, including Volunteer Co-ordination, assisting in Health Promotion education, the NSP and is currently the HCV Peer Educator and a POCT operator in the Deen Clinic and in outreach.

A/Prof Thomas Tu leads the Hepatitis B research group at the Westmead Institute for Medical Research and is a world leader Hepatitis B virology. Drawing on lived experience of hepatitis B, he is committed to translational research that improves outcomes for affected communities.

Josh Borja works at ASHM, supporting the delivery of the HIV s100 Prescriber Course and its associated ongoing education. His work focuses on high-quality training, accreditation, and continuous professional development, helping prescribers build confidence, maintain currency, and strengthen HIV care across Australia. This work extends across the broader blood-borne virus sector, including viral hepatitis. He facilitates "Ask Us Anything" sessions that put lived experience at the centre of clinician training, and embeds stigma-reduction frameworks such as PozQoL into clinical education.